COVID-19 vaccine effectiveness in preventing deaths among high-risk sgroups in Tamil Nadu, India.
作者信息
Jaiswal Anoop, Subbaraj V, Vivian Thangaraj Jeromie Wesley, Murhekar Manoj V, Muliyil Jayaprakash
机构信息
Tamil Nadu Police department, Government of Tamil Nadu, Chennai 600 004, Tamil Nadu, India.
Department of Epidemiology, ICMR-National Institute of Epidemiology, Chennai 600 077, Tamil Nadu, India.
出版信息
Indian J Med Res. 2021 May;153(5&6):689-691. doi: 10.4103/ijmr.ijmr_1671_21.
Abstract
摘要
相似文献
1
COVID-19 vaccine effectiveness in preventing deaths among high-risk sgroups in Tamil Nadu, India.新冠病毒疾病疫苗在印度泰米尔纳德邦高危人群中预防死亡的有效性
Indian J Med Res. 2021 May;153(5&6):689-691. doi: 10.4103/ijmr.ijmr_1671_21.
2
Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India - a community based survey.印度泰米尔纳德邦城乡社区对 COVID-19 疫苗的态度和疫苗犹豫——一项基于社区的调查。
BMC Health Serv Res. 2021 Sep 21;21(1):994. doi: 10.1186/s12913-021-07037-4.
3
The burden of COVID-19 infection in a rural Tamil Nadu community.印度泰米尔纳德邦农村社区的 COVID-19 感染负担。
BMC Infect Dis. 2021 Oct 28;21(1):1110. doi: 10.1186/s12879-021-06787-0.
4
Delta threatens rural regions that dodged earlier COVID waves.德尔塔毒株威胁到了此前躲过新冠疫情浪潮的农村地区。
Nature. 2021 Aug;596(7872):325-326. doi: 10.1038/d41586-021-02146-w.
5
Management of gastrointestinal services in Tamil Nadu, India, during COVID-19.印度泰米尔纳德邦在2019冠状病毒病疫情期间的胃肠病服务管理
Lancet Gastroenterol Hepatol. 2021 Aug;6(8):609-610. doi: 10.1016/S2468-1253(21)00193-X. Epub 2021 Jun 3.
6
Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.新冠病毒疫苗在预防感染和疾病严重程度方面的有效性：来自印度东部邦的一项病例对照研究。
Epidemiol Infect. 2021 Oct 11;149:e224. doi: 10.1017/S0950268821002247.
7
A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.一项病例对照研究，评估含麻疹疫苗预防儿童严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的效果。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3316-3321. doi: 10.1080/21645515.2021.1930471. Epub 2021 Jun 15.
8
Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India.新冠疫情第二波期间印度医护人员接种新冠疫苗的保护作用
Mayo Clin Proc. 2021 Sep;96(9):2493-2494. doi: 10.1016/j.mayocp.2021.06.003. Epub 2021 Jun 26.
9
Mathematical modeling of SARS-nCoV-2 virus in Tamil Nadu, South India.印度南部泰米尔纳德邦 SARS-nCoV-2 病毒的数学建模。
Math Biosci Eng. 2022 Aug 9;19(11):11324-11344. doi: 10.3934/mbe.2022527.
10
COVID-19 Vaccine Uptake in Patients with Ocular Surface Diseases in India.印度眼表疾病患者的新冠疫苗接种情况
Semin Ophthalmol. 2022 Feb 17;37(2):193-194. doi: 10.1080/08820538.2021.1950778. Epub 2021 Jul 8.
引用本文的文献
1
Biometric Strategies to Improve Vaccine Immunogenicity and Effectiveness.提高疫苗免疫原性和有效性的生物识别策略。
Biomimetics (Basel). 2025 Jul 3;10(7):439. doi: 10.3390/biomimetics10070439.
2
Vaccination and COVID-19 infection among adults aged 45 years and above in a North-Eastern state of India.印度东北部某邦45岁及以上成年人中的疫苗接种与新冠病毒感染情况
J Family Med Prim Care. 2022 Oct;11(10):6375-6379. doi: 10.4103/jfmpc.jfmpc_506_22. Epub 2022 Oct 31.
3
Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis.印度孟买医护人员中新冠疫苗（CovishieldTM 和 Covaxin ®）的有效性：一项回顾性队列分析。
PLoS One. 2022 Oct 27;17(10):e0276759. doi: 10.1371/journal.pone.0276759. eCollection 2022.
4
Clinical characteristics and outcome of patients presenting to emergency department during the second wave of COVID-19.第二波新冠疫情期间急诊科患者的临床特征与转归
J Family Med Prim Care. 2022 Jun;11(6):2723-2728. doi: 10.4103/jfmpc.jfmpc_1726_21. Epub 2022 Jun 30.
5
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.系统评价评估 COVID-19 疫苗真实世界有效性的方法学研究：为资源有限环境提供建议。
PLoS One. 2022 Jan 11;17(1):e0261930. doi: 10.1371/journal.pone.0261930. eCollection 2022.
本文引用的文献
1
Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India.新冠疫情第二波期间印度医护人员接种新冠疫苗的保护作用
Mayo Clin Proc. 2021 Sep;96(9):2493-2494. doi: 10.1016/j.mayocp.2021.06.003. Epub 2021 Jun 26.
2
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.苏格兰的新冠病毒德尔塔变异株：人口统计学、住院风险及疫苗有效性
Lancet. 2021 Jun 26;397(10293):2461-2462. doi: 10.1016/S0140-6736(21)01358-1. Epub 2021 Jun 14.
3
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.一剂接种和加强针接种时间对 ChAdOx1 nCoV-19（阿斯利康）疫苗免疫原性和有效性的影响：四项随机试验的 pooled 分析。
Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19.
4
Field evaluation of vaccine efficacy.疫苗效力的现场评估。
Bull World Health Organ. 1985;63(6):1055-68.
Zotero 插件